Highmark Inc: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 6, 2012 17 Pages - SKU: ICDR6793326 |
| Synopsis ICD Research's Highmark Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, plus information on key news events affecting the company. Summary ICD Research's Highmark Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about Highmark Inc.. ICD Research's Highmark Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Highmark Inc. (Highmark) is a provider of health care solutions to employers and individualsin Pennsylvania. The company is a licensee of Blue Cross and Blue Shield Association, serving 4.6million members through the company's health care benefits business. Through its subsidiaries, the company provides dental insurance, vision care products & services, and also life, disability and administrative services and support community-based programs that work to improve people's health. It also provides prescription drug plans to seniors in Pennsylvania and West Virginia regions. The company is headquartered at Pittsburgh in Pennsylvania, United States. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

